Creative Biolabs announces upgraded downstream services designed to bridge the gap between raw antibody expression and advanced preclinical development. SHIRLEY, NY ...
“The efficiency of downstream processing determines the ultimate viability of a lead candidate,” says Dr. Simon Hu, Chief Scientific Officer at Creative Biolabs. “Our goal is to provide a seamless ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果